Having trouble accessing articles? Reset your cache.

MultiStem: Phase I data

In an open-label, dose-escalation, U.S. Phase I trial in 25 patients, single infusions of all doses of MultiStem delivered via a catheter

Read the full 224 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE